CASTLE BIOSCIENCES, INC. (CSTL) Return on equity 2019–2025
CASTLE BIOSCIENCES, INC. (CSTL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-5.1%FY2025 · since FY2019: 6.2% → -5.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.1% | -9.1 pp |
| FY2024 | 4.0% | +18.7 pp |
| FY2023 | -14.7% | +2.1 pp |
| FY2022 | -16.8% | -9.2 pp |
| FY2021 | -7.6% | -5.1 pp |
| FY2020 | -2.5% | -8.7 pp |
| FY2019 | 6.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice